In pursuit of the normal progressor: the holy grail for ALS clinical trial design?

Publication date

2020-01-02

Authors

Van Eijk, Ruben P.A.ORCID 0000-0002-7132-5967
van den Berg, LeonardISNI 0000000388137302

Editors

Advisors

Supervisors

Document Type

Editorial

Collections

Open Access logo

License

taverne

Abstract

Keywords

Taverne, Clinical Neurology, Neurology, Journal Article

Citation

van Eijk, R P A & van Den Berg, L H 2020, 'In pursuit of the normal progressor : the holy grail for ALS clinical trial design?', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 21, no. 1-2, pp. 1-2. https://doi.org/10.1080/21678421.2019.1675710